NewsMV
Hong Kong's IPO market has crossed $40 billion in fundraising, with Hong Kong Exchanges and Clearing chief executive Chan saying the pipeline extends beyond technology to cover sectors that earlier cycles largely skipped.
Biotechnology, mining, and consumer companies are in the queue, Chan said. The $40 billion total is what puts HKEX in focus as the headline number. Chan's sector breakdown is the more instructive read.
A pipeline that now pulls in biotech, mining, and consumer names carries different demand dynamics at the institutional level.
Each sector attracts a distinct base of analyst coverage and fund mandates, and that mix shapes how individual books get built. Biotechnology issuers bring clinical-stage risk that technology deals generally don't carry.
Keep reading